Companies / BOC Sciences / Enfortumab
BOC Sciences

Enfortumab | BOC Sciences

Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab has been used for the treatment of urothelial cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.